ENSC
ENSC
NASDAQ · Biotechnology

Ensysce Biosciences Inc

$0.46
+0.00 (+0.52%)
As of Feb 8, 2:35 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 261.9K 257.5K 229.4K
Net Income -16,622 -16,876 -13,616
EPS
Profit Margin -6.4% -6.6% -5.9%
Rev Growth -9.5% +2.0% +15.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 433.3K 414.2K 358.8K
Total Equity 1.31M 1.33M 1.24M
D/E Ratio 0.33 0.31 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -23,157 -21,131 -19,685
Free Cash Flow -18,370 -13,268 -16,406